125 related articles for article (PubMed ID: 19852016)
1. Fast prediction of cytochrome P450 mediated drug metabolism.
Rydberg P; Vasanthanathan P; Oostenbrink C; Olsen L
ChemMedChem; 2009 Dec; 4(12):2070-9. PubMed ID: 19852016
[TBL] [Abstract][Full Text] [Related]
2. Prediction of activation energies for aromatic oxidation by cytochrome P450.
Rydberg P; Ryde U; Olsen L
J Phys Chem A; 2008 Dec; 112(50):13058-65. PubMed ID: 18986131
[TBL] [Abstract][Full Text] [Related]
3. Regioselectivity prediction of CYP1A2-mediated phase I metabolism.
Jung J; Kim ND; Kim SY; Choi I; Cho KH; Oh WS; Kim DN; No KT
J Chem Inf Model; 2008 May; 48(5):1074-80. PubMed ID: 18412330
[TBL] [Abstract][Full Text] [Related]
4. CypScore: Quantitative prediction of reactivity toward cytochromes P450 based on semiempirical molecular orbital theory.
Hennemann M; Friedl A; Lobell M; Keldenich J; Hillisch A; Clark T; Göller AH
ChemMedChem; 2009 Apr; 4(4):657-69. PubMed ID: 19243088
[TBL] [Abstract][Full Text] [Related]
5. Site of metabolism prediction for six biotransformations mediated by cytochromes P450.
Zheng M; Luo X; Shen Q; Wang Y; Du Y; Zhu W; Jiang H
Bioinformatics; 2009 May; 25(10):1251-8. PubMed ID: 19286831
[TBL] [Abstract][Full Text] [Related]
6. A pragmatic approach using first-principle methods to address site of metabolism with implications for reactive metabolite formation.
Hsiao YW; Petersson C; Svensson MA; Norinder U
J Chem Inf Model; 2012 Mar; 52(3):686-95. PubMed ID: 22299574
[TBL] [Abstract][Full Text] [Related]
7. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
Liu R; Liu J; Tawa G; Wallqvist A
J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
[TBL] [Abstract][Full Text] [Related]
8. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
[TBL] [Abstract][Full Text] [Related]
9. Computational prediction of binding affinity for CYP1A2-ligand complexes using empirical free energy calculations.
Vasanthanathan P; Olsen L; Jørgensen FS; Vermeulen NP; Oostenbrink C
Drug Metab Dispos; 2010 Aug; 38(8):1347-54. PubMed ID: 20413725
[TBL] [Abstract][Full Text] [Related]
10. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2.
Guengerich FP; Krauser JA; Johnson WW
Biochemistry; 2004 Aug; 43(33):10775-88. PubMed ID: 15311939
[TBL] [Abstract][Full Text] [Related]
11. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
12. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
13. SyGMa: combining expert knowledge and empirical scoring in the prediction of metabolites.
Ridder L; Wagener M
ChemMedChem; 2008 May; 3(5):821-32. PubMed ID: 18311745
[TBL] [Abstract][Full Text] [Related]
14. Kinetic isotope effects implicate a single oxidant for cytochrome P450-mediated O-dealkylation, N-oxygenation, and aromatic hydroxylation of 6-methoxyquinoline.
Dowers TS; Jones JP
Drug Metab Dispos; 2006 Aug; 34(8):1288-90. PubMed ID: 16714370
[TBL] [Abstract][Full Text] [Related]
15. Predicting activation enthalpies of cytochrome-P450-mediated hydrogen abstractions. 2. Comparison of semiempirical PM3, SAM1, and AM1 with a density functional theory method.
Mayeno AN; Robinson JL; Yang RS; Reisfeld B
J Chem Inf Model; 2009 Jul; 49(7):1692-703. PubMed ID: 19522482
[TBL] [Abstract][Full Text] [Related]
16. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
McGinnity DF; Parker AJ; Soars M; Riley RJ
Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
[TBL] [Abstract][Full Text] [Related]
17. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
19. A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data.
Lu C; Miwa GT; Prakash SR; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jan; 35(1):79-85. PubMed ID: 17020957
[TBL] [Abstract][Full Text] [Related]
20. Autoactivation and activation of the cytochrome P450s.
Ekins S; Ring BJ; Binkley SN; Hall SD; Wrighton SA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):642-51. PubMed ID: 9877001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
